These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 575119)
41. Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumor. Bassett JB; Anderson RU; Tacker JR J Urol; 1986 Mar; 135(3):612-5. PubMed ID: 3944919 [TBL] [Abstract][Full Text] [Related]
42. Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer. Mizoguchi H; Nomura Y; Terada K; Nakagawa M; Ogata J Int J Urol; 1995 Mar; 2(1):17-23. PubMed ID: 7614405 [TBL] [Abstract][Full Text] [Related]
43. [Antitumor effect of combined use of purified human natural tumor necrosis factor (N-TNF) and cis-diamminedichoroplatinum (II) (cisplatin) on the implanted bladder carcinoma (MBT-2) in mice]. Sasaki A; Ohtani M; Miyanaga N; Zhongtao H; Akaza H; Koiso K; Noguchi R; Takanashi R Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1696-702. PubMed ID: 1434274 [TBL] [Abstract][Full Text] [Related]
44. Radiochemotherapy in locally invasive non-metastatic carcinoma of the bladder. Brod JL; Kühn R; Schafhauser W; Schrott KM Adv Exp Med Biol; 2003; 539(Pt A):143-53. PubMed ID: 15088903 [TBL] [Abstract][Full Text] [Related]
45. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy]. Momose H; Arai K; Nakagawa Y; Fujimoto K; Tsujimoto S; Cho M; Tani Y; Saka M; Nakatsuji F; Iwai A Hinyokika Kiyo; 1989 May; 35(5):781-8. PubMed ID: 2478001 [TBL] [Abstract][Full Text] [Related]
46. Relationship between thiol depletion and chemosensitization in a transplantable murine bladder tumor. Tomashefsky P; Astor M; White RD J Natl Cancer Inst; 1985 Jun; 74(6):1233-8. PubMed ID: 3858595 [TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder. Sumiyoshi Y; Yokota K; Akiyama M; Inoue Y; Yoneda F; Tsujimura H; Nakajima M; Yokozeki H; Maebayashi K J Urol; 1994 Aug; 152(2 Pt 1):362-6. PubMed ID: 8015072 [TBL] [Abstract][Full Text] [Related]
48. Methotrexate given concurrently with radiotherapy in the treatment of transitional cell carcinoma. Tomlinson MJ; Lancaster JF; Bullimore JA; Smith PJ Br J Radiol; 1988 Oct; 61(730):959-60. PubMed ID: 3191325 [No Abstract] [Full Text] [Related]
49. Immunochemotherapy of bladder carcinoma with glucan and cyclophosphamide. Thompson IM; Spence CR; Lamm DL; DiLuzio NR Am J Med Sci; 1987 Nov; 294(5):294-300. PubMed ID: 3425579 [TBL] [Abstract][Full Text] [Related]
50. Chemo-radiation therapy of bladder cancer. Lange CS; Rotman M Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):817-9. PubMed ID: 2211234 [No Abstract] [Full Text] [Related]
52. Effect of chemotherapeutic agents on bladder cancer: a new animal model. Soloway MS; deKernion JB; Rose D; Persky L Surg Forum; 1973; 24():542-4. PubMed ID: 4806091 [No Abstract] [Full Text] [Related]
53. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363 [TBL] [Abstract][Full Text] [Related]
54. Systemic therapy of bladder cancer. Salem PA Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726 [No Abstract] [Full Text] [Related]
55. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice]. Yamauchi T; Okada K; Yoshida O Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129 [TBL] [Abstract][Full Text] [Related]
56. Chemotherapy of bladder cancer: current status and prospects. Smith WK; Koontz WW Va Med; 1979 Feb; 106(2):131-4. PubMed ID: 425674 [No Abstract] [Full Text] [Related]
58. Overall treatment time in the radiotherapy of transitional cell cancer of the bladder. Kleineidam M; Dubben HH Radiother Oncol; 1992 Apr; 23(4):270-1. PubMed ID: 1609134 [No Abstract] [Full Text] [Related]
59. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report]. Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872 [TBL] [Abstract][Full Text] [Related]
60. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study]. Chauvet B; Félix-Faure C; Davin JL; Berger C; Vincent P; Reboul F Cancer Radiother; 1998 Apr; 2 Suppl 1():77s-81s. PubMed ID: 9749084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]